rpr 100893 has been researched along with valproic acid in 1 studies
*Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. [MeSH]
*Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. [MeSH]
| Studies (rpr 100893) | Trials (rpr 100893) | Recent Studies (post-2010) (rpr 100893) | Studies (valproic acid) | Trials (valproic acid) | Recent Studies (post-2010) (valproic acid) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 14,155 | 1,256 | 5,108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, N | 1 |
1 review(s) available for rpr 100893 and valproic acid
| Article | Year |
|---|---|
[Migraine and neurotransmitters].
Topics: GABA Agents; Indoles; Isoindoles; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Serotonin Antagonists; Sumatriptan; Valproic Acid | 1998 |